Barclays’s aTyr Pharma ATYR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.5M | Buy |
296,586
+59,495
| +25% | +$302K | ﹤0.01% | 2415 |
|
|
2025
Q1 | $716K | Buy |
237,091
+77,684
| +49% | +$235K | ﹤0.01% | 2630 |
|
|
2024
Q4 | $577K | Buy |
+159,407
| New | +$577K | ﹤0.01% | 2968 |
|
|
2024
Q2 | – | Sell |
-604,299
| Closed | -$1.18M | – | 4354 |
|
|
2024
Q1 | $1.18M | Buy |
604,299
+525,327
| +665% | +$1.02M | ﹤0.01% | 2285 |
|
|
2023
Q4 | $111K | Buy |
+78,972
| New | +$111K | ﹤0.01% | 3693 |
|
|
2019
Q2 | – | Sell |
-4
| Closed | – | – | 4467 |
|
|
2019
Q1 | $0 | Sell |
4
-1
| -20% | – | ﹤0.01% | 4440 |
|
|
2018
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 4440 |
|
|
2018
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 4506 |
|
|
2018
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 4419 |
|
|
2018
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 4415 |
|
|
2017
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 4220 |
|
|
2017
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 4161 |
|
|
2017
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 4110 |
|
|
2017
Q1 | $0 | Sell |
5
-404
| -99% | – | ﹤0.01% | 4176 |
|
|
2016
Q4 | $12K | Buy |
409
+407
| +20,350% | +$11.9K | ﹤0.01% | 3230 |
|
|
2016
Q3 | $0 | Sell |
2
-65
| -97% | – | ﹤0.01% | 4082 |
|
|
2016
Q2 | $3K | Buy |
67
+55
| +458% | +$2.46K | ﹤0.01% | 3224 |
|
|
2016
Q1 | $0 | Sell |
12
-21
| -64% | – | ﹤0.01% | 3704 |
|
|
2015
Q4 | $4K | Buy |
33
+31
| +1,550% | +$3.76K | ﹤0.01% | 2950 |
|
|
2015
Q3 | $0 | Sell |
2
-61
| -97% | – | ﹤0.01% | 4138 |
|
|
2015
Q2 | $16K | Buy |
+63
| New | +$16K | ﹤0.01% | 3080 |
|